Categories

Tag: Uncategorized

BLOGS: Healthcare blog 100

So a couple of people have pointed me to the Healthcare 100. I was amused elated to find that I am #8. Actually it’s not really a health care blog list, it’s a health care and medical blog list. And the #1 is London Ambulance man who writes Random Acts of Reality. But then I was crushed to find on davidrothman.net that only a few days ago I was in the top 5. Now THCB is in free fall!

More seriously, it’s a fun list, but probably the leading blog in all of health care (certainly in term of revenue generation), HISTalk, isn’t on it

JOB POST: Data analyst – IPRO

IPRO,
one of the leading health care quality improvement organizations in the
United States, is seeking a talented, motivated individual to bolster
our health informatics analysis in the production of Web-based health
care report cards. The position is part-time (22.5 hrs. per week), and
the work week is flexible.

IPRO’s clients include federal and
state agencies, health care providers, managed care organizations,
commercial insurers, corporations, business coalitions and unions.

Continue reading…

HEALTH2.0/TECH: Another Health2.0 aquisition–Healia snapped up by magazine & publishing giant

Healia, one of the leading new health care vertical search engines, despite being an early stage start-up, has already attracted the attention of the big boys. And one of them, Meredith the publisher of lots of female-aimed magazines, decided that it liked it so much it bought the company yesterday. It’s going to use the technology at home, and then try to sell it on.

In addition, Meredith and Healia will expand the functionality of Healia.com and will offer the technology through licensing and distribution agreements with select health organizations, consumer Web sites, employers and other premier partners.

Hopefully they’ll let it alone enough to let Tom Eng and his team keep building it out.

POLICY: Eye-candy, Channel swimming and care for the uninsured.

This kid (young man’s name is John Heineman) is swimming the English channel to raise money for a free clinic in Iowa. His aunt wrote to me pointing it out, and he certainly sounds like a very interesting and incredibly determined guy. He’s combining an interest in health policy with charity work and incredible sporting fortitude/insanity. Even thought he went to Oxford, I wish him lots of luck.

Of course the picture is for enjoyment of the female/gay readers of THCB!

Bilde

PHARMA/POLICY: Crackpots at Hoover

The NY Times gives an op-ed to a crackpot called Henry Miller who used to be a minor official at FDA and is now with the other loonies at Hoover. It’s called Crackpot Legislation in which he goes after those states allowing smoked medical marijuana as medicine. In this op-ed he apparently with a straight face can say this:

When presented with a cannabinoid development program that comports with modern scientific principles, both the F.D.A. and the D.E.A. have demonstrated their willingness to allow it to proceed.

This is complete and utter bullshit. The FDA has with the rest of the US government (including the crackheads at NIDA) in preventing the use of marijuana in clinical trials and medical testing for decades, despite the IOM study. Here’s a statement from a DEA judge (!) on the topic in March.

"NIDA’s system for evaluating requests for marijuana for research has resulted in some researchers who hold DEA registrations and requisite approval from the Dept. of Health and Human Services being unable to conduct their research because NIDA has refused to provide them with marijuana"

Two tiny smoked marijuana studies (including the Abrams one he cites) have been finally allowed after decades of pressure from academics, and now Sativex is being allowed into clinical trials because a) it has a pharmaceutical company behind it which is going to make money off it, and b) because the Brits and Canadians have already allowed it on the market. That action, after thirty years of preventing research into the medical usefulness of marijuana for purely political reasons, does not suggest anything like what Miller calls “willingness.”

Miller thinks that the FDA should be allowed to regulate marijuana. But of course the US government already does regulate marijuana. It’s been a schedule 1 drug, banned since 1937 by Congress incidentally against the then wishes of the AMA with no debate. So what is the FDA’s likely vote on the matter now? To continue the ban of course. Which is why medical marijuana proponents are opposing the amendment to allow the FDA to regulate them, as it’s a back door way of outlawing the progress made at the state level.

The NY Times should be asking itself why it’s allowing such a bunch of half-truths to be published when somewhere between 60 and 80% of Americans are in favor of legalizing medical marijuana, and it’s abundantly clear to anyone that the reasons for the continued ban is the politically and economically-inspired persecution of people who want to use marijuana—whether for medicine or pleasure.

And if Miller really thinks that the current drug-policy powers that be will allow Sativex to get past the FDA and be openly sold in the US, then he really is a crackpot.

Health 2.0: Priming the pump- Jump starting health care consumerism By Scott Shreeve MD

Scott Shreeve co-founded MedSphere, the Southern Californian open source distributor of the VistA EHR. His latest effort is Crossover Healthcare. Scott has been tracking recent developments in the consumer driven health plan sector. Today he shares his take on a series of reports that suggest the CDHP movement may be faltering. The following piece was originally published on his blog, which can be found here.   

Jumpstart (jŭmp stärt) v.

1. Starting an automobile engine that has a weak battery by means of jumper cables 2. Start or re-start in a vigorous manner3. Start something by tapping into another source of power

A recent report by the Wall Street Journal casts some concern over the vitality and validity of the entire consumer driven health movement. The critique provides some hard numbers regarding the actual uptake in numbers which is significantly less than some other reports indicate. Worse still, a recent report by Towers Perrin indicated that many people with HDHP plans are dissatisfied with their consumer experience to date.

Continue reading…

THCB: Tech section with UPDATE

Over the next few weeks or so you’ll see some changes at
THCB. Most importantly, we’ll be launching the Tech Section, a new area of the site specifically focused on
healthcare and technology. Stories on healthcare, technology and IT subjects
will live here, as will archived podcasts and our rapidly expanding collection
of Health 2.0 focused content.
You’ll also find guest posts by special guest contributors working in the field,
ranging from execs at top hospital and health plan systems, to experts at the forefront of the industry.

Meanwhile, if you want to reach a monthly audience of tens of thousands
of healthcare industry observers interested in the intersection of technology
and healthcare and related stories, you may want to consider  sponsoring THCB or one of our sections. We’re read “religiously” throughout the
industry, by readers who like our “irreverent’ and “influential” coverage of trends and issues (Wall Street Journal.)  Monthly and longer term corporate sponsorships are available.  A limited number of Health 2.0 sponsorships remain
as well. Contact jo**@***************og.com
for rates, availability and other details.